EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Bone Marrow Aspirate Concentrate May Decrease Reoperation in Osteochondral Allograft Transplantation: A Prospective, Randomized, Double‐Blind Investigation

Adam B Yanke, Navya Dandu, Blake M Bodendorfer, Nicholas A Trasolini, Mario Hevesi, Tristan J Elias, Erik Haneberg, Reem Y Darwish, Athan Zavras, Brian Forsythe, Brian J Cole

Arthroscopy · 2025-11 · 41 (11) · 4664

DOI: 10.1016/j.arthro.2025.05.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Arthroscopy, online erschienen am 05.06.2025. Verfasst von Adam B Yanke und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rush University Medical Center, Chicago, Illinois, U.S.A.. Electronic address: adam.yanke@rushortho.com. Hauptthemen laut MEDLINE: Bone Marrow Transplantation, Knee Joint, Bone Transplantation, Cartilage, Articular. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Ajinomoto Animal Nutrition North America, JRF Ortho.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To perform a prospective, double‐blind, randomized controlled trial to assess differences in integration and patient‐reported outcomes metrics (PROMs) of osteochondral allograft transplantation with and without bone marrow aspirate concentrate (BMAC) augmentation.

Methods

Patients (n = 36) undergoing osteochondral allograft transplantation of the knee were consented and enrolled in this prospective study. They were randomized to either iliac crest BMAC or sham incision groups and blinded to their allocation. Computerized tomography (CT) scans of the knee were obtained at 6 months postoperatively after the index transplantation and graded by the semiquantitative assessment CT osteochondral allograft system. PROMs, including the International Knee Documentation Committee and Knee injury and Osteoarthritis Outcome Score–Joint Replacement, were obtained at 6 months, 1 year, and 2 years postoperatively.

Results

On 6‐month postoperative CT scans, patients receiving BMAC‐treated grafts were more likely to have small cystic changes ( P = .01), with an associated trend toward reduction in large cyst formation ( P = .06), but equal osseous integration, graft signal density, and presence of discernible clefts and intra‐articular fragments. The BMAC group was less likely to undergo subsequent surgery for graft debridement or revision (5.3% vs 35.3%; P = .02). There were no significant differences in PROMs between the 2 groups preoperatively or postoperatively at 6 months, 1 year, or 2 years. Patients receiving BMAC trended toward a higher rate of achievement of Knee Documentation Committee and Knee injury and Osteoarthritis Outcome Score–Joint Replacement minimal clinically important difference (88% vs 55%; P = .076).

Conclusions

Patients receiving BMAC‐treated grafts were more likely to have small cystic changes and were less likely to undergo subsequent surgery for persistent or new symptoms after the index procedure. No difference in postoperative PROMs was shown at the 6‐month, 1‐year, and 2‐year follow‐ups between the 2 groups. Level of Evidence Level I, prospective, randomized controlled trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Marrow TransplantationKnee JointBone TransplantationCartilage, ArticularHumansDouble-Blind MethodMaleFemaleProspective StudiesAdultMiddle AgedReoperationAllograftsTransplantation, HomologousTomography, X-Ray ComputedPatient Reported Outcome MeasuresTreatment Outcome

Autor:innen und Institutionen

  • Rush University Medical Center, Chicago, Illinois, U.S.A.. Electronic address: adam.yanke@rushortho.com.
  • Rush University Medical Center, Chicago, Illinois, U.S.A.; Alleghany General Hospital, Pittsburgh, Pennsylvania, U.S.A.
  • Rush University Medical Center, Chicago, Illinois, U.S.A.
  • Rush University Medical Center, Chicago, Illinois, U.S.A.; Wake Forest Baptist Health, Winston-Salem, North Carolina, U.S.A.
  • Rush University Medical Center, Chicago, Illinois, U.S.A.; Mayo Clinic, Rochester, Minnesota, U.S.A.
  • Alleghany General Hospital, Pittsburgh, Pennsylvania, U.S.A.

Förderung

  • Ajinomoto Animal Nutrition North America
  • JRF Ortho

Zitieren

APA

Yanke, A. B., Dandu, N., Bodendorfer, B. M., Trasolini, N. A., Hevesi, M., Elias, T. J., Haneberg, E., Darwish, R. Y., Zavras, A., Forsythe, B., & Cole, B. J. (2025). Bone Marrow Aspirate Concentrate May Decrease Reoperation in Osteochondral Allograft Transplantation: A Prospective, Randomized, Double‐Blind Investigation. Arthroscopy, 41(11), 4664. https://doi.org/10.1016/j.arthro.2025.05.024

Vancouver

Yanke AB, Dandu N, Bodendorfer BM, Trasolini NA, Hevesi M, Elias TJ, et al. Bone Marrow Aspirate Concentrate May Decrease Reoperation in Osteochondral Allograft Transplantation: A Prospective, Randomized, Double‐Blind Investigation. Arthroscopy. 2025;41(11):4664. doi:10.1016/j.arthro.2025.05.024

BibTeX
@article{Yanke2025,
  author = {Yanke, Adam B and Dandu, Navya and Bodendorfer, Blake M and Trasolini, Nicholas A and Hevesi, Mario and Elias, Tristan J and Haneberg, Erik and Darwish, Reem Y and Zavras, Athan and Forsythe, Brian and Cole, Brian J},
  title = {Bone Marrow Aspirate Concentrate May Decrease Reoperation in Osteochondral Allograft Transplantation: A Prospective, Randomized, Double‐Blind Investigation},
  journal = {Arthroscopy},
  year = {2025},
  volume = {41},
  number = {11},
  pages = {4664},
  doi = {10.1016/j.arthro.2025.05.024}
}
Kostenlos starten →